Immunological and Structural Characterization of Titin Main Immunogenic Region; I110 Domain Is the Target of Titin Antibodies in Myasthenia Gravis
Myasthenia gravis (MG) is an autoimmune disease caused by antibodies targeting the neuromuscular junction (NJ) of skeletal muscles. The major MG autoantigen is nicotinic acetylcholine receptor. Other autoantigens at the NJ include MuSK, LRP4 and agrin. Autoantibodies to the intra-sarcomeric striated...
Main Authors: | Christos Stergiou, Rhys Williams, Jennifer R. Fleming, Vasiliki Zouvelou, Elpinickie Ninou, Francesca Andreetta, Elena Rinaldi, Ornella Simoncini, Renato Mantegazza, Julius Bogomolovas, John Tzartos, Siegfried Labeit, Olga Mayans, Socrates Tzartos |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-02-01
|
Series: | Biomedicines |
Subjects: | |
Online Access: | https://www.mdpi.com/2227-9059/11/2/449 |
Similar Items
-
Anti-titin antibody is associated with more frequent hospitalization to manage thymoma-associated myasthenia gravis
by: Ki Hoon Kim, et al.
Published: (2022-10-01) -
Altered serum levels of cytokines in patients with myasthenia gravis
by: Shu-Li Wei, et al.
Published: (2024-01-01) -
Titin kinase is an inactive pseudokinase scaffold that supports MuRF1 recruitment to the sarcomeric M-line
by: Julijus Bogomolovas, et al.
Published: (2014-01-01) -
Effect of titin phosphorylation on degradation of titin from skeletal muscles
by: Ying Wang, et al.
Published: (2023-07-01) -
Clinical Characteristics and Prognosis of Anti-AChR Positive Myasthenia Gravis Combined With Anti-LRP4 or Anti-Titin Antibody
by: Yuping Chen, et al.
Published: (2022-05-01)